The primary objective of this study is to evaluate the long-term safety and tolerability of ecopipam tablets in children (greater than or equal to [>=] 6 and less than [=12 and =18 years of age) with Tourette's Syndrome (TS).
Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. The鈥�
This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's Disorder (TD). The study includes an open-label period followed by鈥�
137 publications
2022
Movement Disorders Clinical Practice
2021
Movement Disorders Clinical Practice
2021
European journal of neurology
鈥�2021
Movement Disorders
2021
Tremor and other hyperkinetic movements (New York, N.Y.)
鈥�